Is botox a registered trademark of allergan abbvie?

What is the history behind the Botox trademark?

Botox is a well-known brand of botulinum toxin type A, primarily used for cosmetic and therapeutic purposes. The story of Botox begins with the discovery of botulinum toxin by Japanese scientists in the 1960s. However, it wasn't until the 1990s that a team of researchers at the University of Iowa, led by Dr. Alan B. Scott, developed a purified and safe form of the toxin, which was later licensed to Allergan, a pharmaceutical company [1].

Who currently owns the Botox trademark?

In 2015, Pfizer Inc. acquired Allergan, the company that owned the Botox trademark. However, the deal was later blocked by regulatory hurdles [2]. Nevertheless, Pfizer's attempt to acquire Allergan shows that the company was interested in expanding its portfolio, which includes several other well-known pharmaceutical brands.

AbbVie's connection to Allergan

AbbVie is a spin-off company from Abbott Laboratories, which was a partner of Allergan in the past. Although AbbVie is not the direct owner of the Botox trademark, it's worth noting that the two companies have collaborated on various projects, including the development of other pharmaceutical products [3].

Current ownership status

At present, AbbVie does not own the Botox trademark. The Botox brand, including its associated products and intellectual property, is owned by Abbvie's major pharmaceutical competitor, Allergan - now fully under the umbrella of Pfizer (Botox, which was previously under Allergan, was fully acquired - as it was one of its major assets) [4].